251 286 - Biotech Bayern
251 286 - Biotech Bayern
251 286 - Biotech Bayern
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
NascaCell Technologies AG<br />
BIOTECH DEVICES & REAGENTS<br />
Keywords: Drug Development, Aptamer Technology, Peptide/Protein<br />
NascaCell Technologies AG is a global leader in the automated production<br />
and marketing of aptamers and Microbodies. Aptamers are small, functional<br />
oligonucleotides binding to target proteins with very high affinities and<br />
specificities. Because of their drug like binding characteristics, aptamers<br />
typically show strong inhibition of protein function. NascaCell selects aptamers<br />
in a rapid, automated procedure. This allows their generation in 8-10 weeks with<br />
proven track record in target validation and drug discovery. Microbodies are<br />
very small (ca 35 amino acids) and extremely stable proteins. Active peptides<br />
can be grafted or new sequences identified with bacterial display.<br />
Microbodies combine the selectivity of biologic agents with the ease of<br />
handling and storage of small molecule drug compounds.<br />
NeuroProfile GmbH<br />
BIOTECH THERAPEUTICS & DIAGNOSTICS<br />
NeuroProfile is committed to the discovery and development of novel therapeutics<br />
for the treatment of Central Nervous System (CNS) diseases. The main<br />
objective is the identification and commercialization of novel neuronal drug<br />
targets (disease-related genes or proteins) for the most important neurodegenerative<br />
diseases Alzheimer and Parkinson and for psychiatric disorders<br />
such as schizophrenia and depression. Our targets will be the basics for forthcoming<br />
drug generations with new mechanisms of action that not only<br />
ameliorate the disease symptoms, but potentially prevent or block progression<br />
of the disease.<br />
Several patent pending target candidates are run in preclinical validation<br />
projects.<br />
NIGU Chemie GmbH<br />
PHARMA & CHEMICAL INDUSTRY<br />
Nigu offers a full range of high-purity guanidine salts for biotechnological<br />
applications, which meet the supreme quality standards set by the biopharmaceutical<br />
industry. The product group includes several grades of guanidine<br />
hydrochloride for separation and purification of recombinant proteins and antibodies.<br />
Guanidine thiocyanate for nucleic acid based diagnostics is another<br />
integral part of the portfolio. A typical example is to provide guanidine-salts<br />
and recycling of used solutions as a complete package to the biopharmaceutical<br />
industry.<br />
Contact:<br />
Dr. Michael Szardenings<br />
Max-Lebsche-Platz 31<br />
3. OG, Modul D<br />
D-81377 München<br />
Phone: +49 (0) 89 54 72 72 10<br />
Fax: +49 (0) 89 54 72 72 22<br />
E-Mail: customer@nascacell.de<br />
Internet: www.nascacell.de<br />
Contact:<br />
Dr. Thomas Rohrmeier<br />
Josef-Engert-Str. 9<br />
D-93053 Regensburg<br />
Phone: +49 (0) 941 7853690<br />
Fax: +49 (0) 941 7853699<br />
E-Mail: info@neuroprofile.com<br />
Internet: www.neuroprofile.com<br />
Contact:<br />
Dr. Frank Fleischer<br />
Beuthener Str. 2<br />
D-84478 Waldkraiburg<br />
Phone: +49 (0) 8638 962-0<br />
Fax: +49 (0) 8638 962-<strong>286</strong><br />
E-Mail: info@nigu.de<br />
Internet: www.nigu.de<br />
89